SCHEMBL9608518

SCHEMBL9608518

CC(=O)c1cc(C)cc(-c2nc(-c3ccccc3O)nc(-c3ccccc3O)n2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.47
ADORA2A P29274 2/20 0.47
ADORA3 P0DMS8 1/20 0.47
ALOX15 P16050 1/20 0.47
ADORA2B P29275 1/20 0.47
ADORA1 P30542 1/20 0.47
KMT2A Q03164 7/20 0.46
MAPK1 P28482 4/20 0.45
ALDH1A1 P00352 5/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 8/20 0.42
NPSR1 Q6W5P4 7/20 0.42
MEN1 O00255 5/20 0.42
KDM4E B2RXH2 5/20 0.42
HPGD P15428 3/20 0.42
LMNA P02545 3/20 0.42
NPC1 O15118 1/20 0.42
HSD17B10 Q99714 4/20 0.41
HTT P42858 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9609336 0.91 ADORA2A (0.51) TSHRADORA2AADORA3ALOX15ADORA2B
SCHEMBL9608510 0.85 MAPT (0.54) TSHRADORA2AADORA3ALOX15ADORA2B
SCHEMBL9608494 0.82 ADORA2A (0.57) TSHRADORA2AADORA3ALOX15ADORA2B
SCHEMBL9608397 0.80 ADORA2A (0.57) TSHRADORA2AADORA3ALOX15ADORA2B
SCHEMBL12820208 0.79 KMT2A (0.55) TSHRADORA2AADORA3ALOX15ADORA2B
SCHEMBL9608515 0.78 TSHR (0.44) TSHRADORA2AADORA3ALOX15ADORA2B
SCHEMBL9609308 0.77 TSHR (0.57) TSHRADORA2AADORA3ALOX15ADORA2B
SCHEMBL9608511 0.76 POLB (0.48) TSHRADORA2AADORA3ALOX15ADORA2B
SCHEMBL15417612 0.76 ADORA2A (0.55) TSHRADORA2AADORA3ALOX15ADORA2B
SCHEMBL15417604 0.75 MAPT (0.55) TSHRADORA2AADORA3ALOX15ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8957140-B2 Triazine derivative, ultraviolet absorber, and resin composition FUJIFILM CORPORATION (JP) 2015-02-17 US disclosed
US-8748520-B2 Polycarbonate resin composition containing triazine compound and molded article using the same FUJIFILM CORPORATION (JP) 2014-06-10 US disclosed
US-8623990-B2 Polyester resin composition FUJIFILM CORPORATION (JP) 2014-01-07 US disclosed
US-20120301696-A1 POLYESTER RESIN COMPOSITION FUJIFILM CORPORATION (JP) 2012-11-29 US disclosed
US-20120136098-A1 NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION FUJIFILM CORPORATION (JP) 2012-05-31 US disclosed
US-20110077331-A1 POLYCARBONATE RESIN COMPOSITION CONTAINING TRIAZINE COMPOUND AND MOLDED ARTICLE USING THE SAME FUJIFILM CORPORATION (JP) 2011-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136098-A1 NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION C1R, RPSA, H1-2 TSHR 914/4885ADORA2A 1612/4885ADORA3 1862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.